PBPs are more than static β lactam targets. Host conditions rewire PBP activity and peptidoglycan architecture, shaping tolerance, resistance, and how we design salvage regimens.
Cody A. Black, PharmD, PhD, BCIDP
Advertisement
Black is an NIH/NCATS T32 postdoctoral research fellow at UT Health San Antonio and an adjoint assistant professor at The University of Texas at Austin College of Pharmacy. A clinical staff pharmacist at University Hospital (San Antonio), his work centers on antimicrobial resistance, β-lactam pharmacology, and translational infectious diseases research. (ORCID: 0000-0003-0020-0216)
Articles by Cody A. Black, PharmD, PhD, BCIDP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Dynavax and Vaxart Partner to Advance Oral COVID-19 Vaccine
2
Penicillin-Binding Proteins Reconsidered: A Clinician's Guide from Targets to Dynamic Cell-Wall Control
3
Using Doxycycline for Post-Exposure Prevention of Lyme Disease in Young Kids
4
